| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1389466B1 A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1328546B1 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1290006B1 Combinatorial production of nucleotide and nucleoside (XITP) analogues |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 02/21/2007 | EP1220687B1 Administration of gamma globulins to treat lymphoma |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |
| 02/21/2007 | EP1165570B9 Novel phosphorus-containing prodrugs |
| 02/21/2007 | EP1140071B1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 02/21/2007 | EP1139980B1 Cosmetic or medical preparation for topical use |
| 02/21/2007 | EP1135374B9 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0797456B1 Anticancer drug with a cytostatic and a contrasting agent |
| 02/21/2007 | CN1918298A Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 02/21/2007 | CN1918170A 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 02/21/2007 | CN1918163A Fused pyrrolocarbazoles and methods for the preparation thereof |
| 02/21/2007 | CN1918162A Novel fused pyrrolocarbazoles |
| 02/21/2007 | CN1918156A Isothiazole dioxides as cxc- and cc-chemokine receptor ligands |
| 02/21/2007 | CN1918148A Substituted benzimidazoles and their use for inducing apoptosis |
| 02/21/2007 | CN1917922A Use of substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917899A Use of alkaline phosphatase for the detoxification of lps |
| 02/21/2007 | CN1917887A The use of o-atp for the treatment of diseases involving angiogenesis |
| 02/21/2007 | CN1917880A Pyrimidines with tie2 (tek) activity |
| 02/21/2007 | CN1917879A Pyrimidines with tie2 (tek) activity |
| 02/21/2007 | CN1917867A Compounds having antitumor activity |
| 02/21/2007 | CN1916174A siRNA sequence of idiosyncratic silent nm23óÄ1, and carrier and application |
| 02/21/2007 | CN1916030A Highly sulfated derivatives of k5 polysaccharide and their preparation |
| 02/21/2007 | CN1916015A Amine, heterocycle of chemical modification object of ursolic acid |
| 02/21/2007 | CN1916009A Process for preparing amine platinum complexes |
| 02/21/2007 | CN1915991A Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 02/21/2007 | CN1915978A Crystal form of lonidamine, preparation method, and composition of containing the crystal form |
| 02/21/2007 | CN1915968A Neutral-cationic lipid for nucleic acid and drug delivery |
| 02/21/2007 | CN1915433A Relativity between AnnexinA3 and drug resistance of platinum type chemical curing medication for cancer |
| 02/21/2007 | CN1915432A Gene medication in use for treating tumor from epithelium, and preparation method |
| 02/21/2007 | CN1915363A Composition of medication for treating tumor, preparation method and application |
| 02/21/2007 | CN1915344A Nutrient for cell growth, preparation method, and application of finished product in treating tumor, cardiovascular and cerebrovascular diseases |
| 02/21/2007 | CN1915335A General flavone of root of lilac daphne, method of extraction, and application |
| 02/21/2007 | CN1915292A Application of acetylcholine esterase inhibitor medication of Yidancao extractive as cholinomimetic |
| 02/21/2007 | CN1915289A Medication for treating breast cancer, lymph cancer of mammary gland, and preparation method |
| 02/21/2007 | CN1915247A A gelatin pill for treating tumour |
| 02/21/2007 | CN1915232A Combination of baicalin and medication of chemical treatment in platinum family |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/21/2007 | CN1915222A Composition of liposome, and preparation method |
| 02/21/2007 | CN1915221A Liposome of alkaloid in vinca, and preparation method |
| 02/21/2007 | CN1915220A Mitoxantrone or liposome of mitoxantrone hydrochloric acid, and preparation method |
| 02/21/2007 | CN1301329C Tumour cell specific eucaryon expressing carriers |
| 02/21/2007 | CN1301267C A simulated epitope peptide of MUC1 mucoprotein and its encoding DNA and use thereof |
| 02/21/2007 | CN1301265C Synthesized polypeptide and application |
| 02/21/2007 | CN1301261C Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid and preparation method thereof |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/21/2007 | CN1301253C Pentatomic sulphur heterocyclic compound and its use for preparing medicine for treating preventing diseases related to adiposity |
| 02/21/2007 | CN1301134C Novel immune effect compound |
| 02/21/2007 | CN1301128C Coixenolide soft capsule for treating prostatic disease |
| 02/21/2007 | CN1301111C Use of phenoxthine compounds in preparing medicnies for promoting radio-sensitive medicines |
| 02/20/2007 | US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179828 Antiproliferative, anticarcinogenic and antifungal agents; food and cosmetic preservatives |
| 02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 02/20/2007 | US7179816 Chemical derivatives and their application as antitelomerase agents |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179646 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179495 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
| 02/20/2007 | US7179445 Cobalamin conjugates useful as imaging and therapeutic agents |
| 02/20/2007 | CA2455050C Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 02/20/2007 | CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 02/20/2007 | CA2325776C Novel analogue compounds of camptothecin, process for preparing them and pharmaceutical compositions containing them |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2218872C Preparation and use of sulfated oligosaccharides |
| 02/20/2007 | CA2218499C Chemokine binding protein and methods of use therefor |
| 02/20/2007 | CA2180156C Self-assembled taxo-diperpenoid nanostructures |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019416A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019346A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | WO2007019116A1 Use of hdac inhibitors for the treatment of myeloma |
| 02/15/2007 | WO2007018818A1 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
| 02/15/2007 | WO2007018469A1 Oxopyridyl quinoline amides as nk3 receptor modulators |
| 02/15/2007 | WO2007018466A1 Alkylpyridyl quinolines as nk3 receptor modulators |
| 02/15/2007 | WO2007018465A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators |
| 02/15/2007 | WO2007018437A1 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 02/15/2007 | WO2007018325A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007018316A1 Prophylactic/therapeutic agent for cancer |
| 02/15/2007 | WO2007018309A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method |
| 02/15/2007 | WO2007018281A1 Akt ACTIVATION INHIBITOR |
| 02/15/2007 | WO2007018278A1 Inhibitor for the onset and progress of liver cancer |
| 02/15/2007 | WO2007018275A1 Design of delivery medium based on rolling model |
| 02/15/2007 | WO2007018273A1 Composition for delivering diagnostic agent containing sugar-modified liposome |